Research articlePublished 2019
Interleukin-8 as a Surrogate Marker in Risk Stratification of Patients with Acute Myeloid Leukemia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: When molecular and cytogenetic studies are not available, the risk stratification of AML patients will be difficult. This study was conducted to evaluate the prognostic value of IL-8 among AML patients with its relation to outcome. Methods: This is a cross sectional study; 42 newly diagnosed AML patients ( 0.05). While significant higher mean was observed among poor cytogenetic risk group (110.4 pg/mL) as well as among died patients (108.8 pg/mL) and refractory patients (84.2 pg/mL). In regard to survival, among those with IL-8>40 pg/mL, the mean survival time was higher in comparison to AML patients with IL-8 ≤ 40 pg/mL (34.6 months vs 26.3 months). Conclusion: This study concluded that serum IL-8 concentration at presentation of AML patients is high and it could be used as a marker for risk stratification for AML patients.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood & Lymph
- SubjectHaematology
- BylineArticles whose byline prints “Mohammed Abdul Wahid Almorish”
- BylineArticles whose byline prints “Waiel Mohmed Abdo Al-Kahiry”
- BylineArticles whose byline prints “Maha Abubakr Feissal Rabie”
- BylineArticles whose byline prints “Enas Ali Mohamed Dammag”
